Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.

Added 408 days ago (25.01.2020)
Authors: Jujić A, Atabaki-Pasdar N, Nilsson PM, Almgren P, Hakaste L, Tuomi T, Berglund LM, Franks PW, Holst JJ, Prasad RB, Torekov SS, Ravassa S, Díez J, Persson M, Melander O, Gomez MF, Groop L, Ahlqvist E, Magnusson M
PubMed id: 31974732
Read article